Materias dentro de su búsqueda.
Mostrando 2,261 - 2,280 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.36s Limitar resultados
  1. 2261
    “…The combination of the direct-acting antivirals, simeprevir (SMV) and sofosbuvir (SOF), was the first highly efficacious interferon-free combination for treating patients with hepatitis C virus (HCV), and was widely used in Italy as a result. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
  2. 2262
    por Madani, Tariq Ahmed
    Publicado 2007
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance
  3. 2263
    “…BACKGROUND AND OBJECTIVES: Although hepatitis C virus (HCV) genotype 4 has been reported to be prevalent in some countries of the Middle East, the genotype distribution in some geographical areas is not conclusive. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence
  4. 2264
    “…At the 3’ end of genomic hepatitis C virus (HCV) RNA there is a highly conserved untranslated region, the 3’X-tail, which forms part of the 3’UTR. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Form confers function: Case of the 3’X region of the hepatitis C virus genome
  5. 2265
    “…Hepatitis C virus (HCV) infection is a blood borne and transfusion-transmitted infection (TTI). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries
  6. 2266
    “…BACKGROUND: It has been suggested that hepatitis C virus (HCV) core+1 protein plays a crucial role in the viral life cycle, potentially affecting liver cirrhosis and the development of hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Relationship between antibodies to hepatitis C virus core+1 protein and treatment outcome
  7. 2267
    “…Patients with chronic hepatitis C have both higher prevalence of diabetes mellitus type 2 (T2DM) and increased cardiovascular risk compared to never infected people. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
  8. 2268
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Distribución del genotipo del Virus de la Hepatitis C en Córdoba
  9. 2269
    “…HCV genotype 2a strain JFH-1 replicates and produces viral particles efficiently in human hepatocellular carcinoma (huh) 7.5 cells, which provide a stable in vitro cell infection system for the hepatitis C virus (HCVcc system). Natural killer (NK) cells are large lymphoid cells that recognize and kill virus-infected cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cytokine-Modulated Natural Killer Cells Differentially Regulate the Activity of the Hepatitis C Virus
  10. 2270
    “…We report the case of a woman with chronic hepatitis C and idiopathic thrombocytopenic purpura (ITP) who developed autoimmune hepatitis (AIH) during antiviral therapy with ledipasvir (LDV)/sofosbuvir (SOF). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
  11. 2271
    “…BACKGROUND: Treatment of HIV-infected men during early hepatitis C virus (HCV) infection with interferon results in a higher cure rate with a shorter duration of treatment than during chronic HCV infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ledipasvir and Sofosbuvir in the Treatment of Early Hepatitis C Virus Infection in HIV-Infected Men
  12. 2272
    “…BACKGROUND AND AIMS: Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
  13. 2273
    “…The latest Association Française pour l’Etude du Foie - French Association for Study of the Liver (AFEF) and European Association for the Study of the Liver (EASL) recommendations announce a change of paradigm, for the management of patients infected with hepatitis C virus (HCV). The AFEF recommendations focus on the elimination of HCV infection on a national level by preventing reinfection, in less than ten years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
  14. 2274
    “…We aimed to evaluate the efficacy and safety of 12-week treatment with ritonavir-boosted paritaprevir and ombitasvir in patients with hepatitis C virus (HCV) genotype 1 infection in a real-world setting. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1
  15. 2275
    “…Well‐tolerated, ribavirin‐free, pangenotypic hepatitis C virus (HCV) treatments for transplant recipients remain a high priority. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
  16. 2276
    “…BACKGROUND: Hepatitis C virus (HCV) infections remain as one of the major public health problems worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of hepatitis C risk factors in center of Iran: A case–control study
  17. 2277
    “…INTRODUCTION: An estimated 25% of the 1.2 million individuals living with human immunodeficiency virus (HIV) in the U.S. are co-infected with hepatitis C (HCV). The Centers for Disease Control and Prevention recommends HCV testing for high-risk groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bundled HIV and Hepatitis C Testing in the Emergency Department: A Randomized Controlled Trial
  18. 2278
    “…Due to the severity of chronic hepatitis C, there are multiple factors that can negatively affect the quality of life of infected patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapies
  19. 2279
    “…BACKGROUND: Hepatitis C Virus infection has been considered an important hidden pandemic in developing countries, particularly in Africa. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016
  20. 2280
    “…The treatment of hepatitis C virus (HCV) infection by combination of direct acting antivirals (DAA), with different mode of action, has made substantial progress in the past few years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture
Herramientas de búsqueda: RSS